Jorge Alcocer‐Varela

Author

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

Also Known As

J ALCOCER-VARELA, J ALCOCERVARELA, J Alcocer-Varela, J. ALCOCER‐VARELA, J. Alcocer-Varela, J. Alcocer‐Varela, Jorge Alcocer-Varela, Jorge Alcocer‐Varela, Jorge Alcocer‐varela, Jorge C. Alcocer-Varela

195

Publications

7.9K

Citations

H-Index

131

Concepts

All Affiliations

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Universidad Nacional Autónoma de México Autonomous University of San Luis Potosí

About

Jorge Alcocer‐Varela is an author at Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán specializing in medicine, autoimmune disease, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	61	4.1K
2	Allergy	13	15	943
3	Health Sciences	4	4	144
4	Public Health	3	3	97
5	Biology	1	1	19

Jorge Alcocer‐Varela

114

Publications

6.9K

Citations

H-Index

Page 1

	Year	Citations
A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans Ludmila Prokunina‐Olsson, Casimiro Castillejo-López, Fredrik Öberg, Nature Genetics Autoimmune DiseaseDisease MechanismLupusMedicineImmunology	2002	753
Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. Luis Llorente, Weiguo Zou, Yves Lévy, The Journal of Experimental Medicine ImmunologyPathologyAnti-il-6 MabImmunotherapyIl-10 Dependent	1995	547
Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus Luis Enrique Montiel Llorente, Yvonne Richaud‐Patín, Carlos García‐Padilla, Arthritis & Rheumatism	2000	462
Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. Jorge Alcocer‐Varela, D Alarcón-Segovia Journal of Clinical Investigation Clinical ImmunologyHealthy SubjectsImmunologyPathologyImmunotherapy	1982	419
Quantification of regulatory T cells in patients with systemic lupus erythematosus José C. Crispín, Jorge Alcocer‐Varela Journal of Autoimmunity InflammationAutoimmune DiseaseSystemic Lupus ErythematosusSystemic Lupus Erythematosus TreatmentLupus	2003	404
In vivo production of interleukin‐10 by non–t cells in rheumatoid arthritis, sjöugren's syndrome, and systemic lupus erythematosus. Luis Llorente, Yvonne Richaud‐Patín, R Fior, Arthritis & Rheumatism	1994	313
Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Luis Llorente, Yvonne Richaud‐Patín, John Wijdenes, PubMed Clinical ImmunologyImmunologyPathologyB LymphocytesImmunotherapy	1994	204
Dysregulation of interleukin‐10 production in relatives of patients with systemic lupus erythematosus Luis Llorente, Yvonne Richaud‐Patín, Jacques Couderc, Arthritis & Rheumatism	1997	132
Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance MI Vargas-Rojas, Yvonne Richaud‐Patín, Jorge Alcocer‐Varela Lupus InflammationAutoimmune DiseaseSystemic Lupus ErythematosusAllergyLupus	2008	125
High levels of TH2 cytokine gene expression in systemic lupus erythematosus. Yvonne Richaud‐Patín, Jorge Alcocer‐Varela, Luis Llorente PubMed InflammationCytokineAutoimmune DiseaseSystemic Lupus ErythematosusSystemic Lupus Erythematosus Treatment	1996	104

Page 1